Canopy Growth Corporation (CGC) Bundle
Understanding Canopy Growth Corporation (CGC) Revenue Streams
Understanding Canopy Growth Corporation’s Revenue Streams
Canopy Growth Corporation reported net revenue of $129,203,000 for the six months ended September 30, 2024, a decrease of $16,650,000 or 11% from $145,853,000 in the same period of 2023.
Breakdown of Primary Revenue Sources
The revenue streams are categorized into four segments:
- Canada Cannabis
- International Markets Cannabis
- Storz & Bickel
- This Works
The following table illustrates the segmented net revenue for the six months ended September 30, 2024, and 2023:
| Segment | 2024 Revenue (CAD) | 2023 Revenue (CAD) | $ Change | % Change |
|---|---|---|---|---|
| Canada Adult-Use Cannabis | $37,271,000 | $48,358,000 | ($11,087,000) | (23%) |
| Canada Medical Cannabis | $37,484,000 | $31,801,000 | $5,683,000 | 18% |
| International Markets Cannabis | $20,142,000 | $19,139,000 | $1,003,000 | 5% |
| Storz & Bickel | $34,306,000 | $30,064,000 | $4,242,000 | 14% |
| This Works | $0 | $13,091,000 | ($13,091,000) | (100%) |
| Other | $0 | $3,400,000 | ($3,400,000) | (100%) |
Year-over-Year Revenue Growth Rate
The year-over-year revenue growth rate for the six months ended September 30, 2024, shows a decline in overall revenue. The following points summarize the trends:
- Canada Cannabis: Total revenue decreased by 7% from $80,159,000 in 2023 to $74,755,000 in 2024.
- International Markets Cannabis: Revenue grew by 5% from $19,139,000 in 2023 to $20,142,000 in 2024.
- Storz & Bickel: Revenue increased by 14% from $30,064,000 in 2023 to $34,306,000 in 2024.
- This Works: Revenue dropped to $0 in 2024 from $13,091,000 in 2023.
Contribution of Different Business Segments to Overall Revenue
The contribution of different business segments to overall revenue for the six months ended September 30, 2024 is as follows:
| Segment | Revenue Contribution (CAD) | Percentage of Total Revenue |
|---|---|---|
| Canada Cannabis | $74,755,000 | 57.8% |
| International Markets Cannabis | $20,142,000 | 15.6% |
| Storz & Bickel | $34,306,000 | 26.6% |
| This Works | $0 | 0% |
Analysis of Significant Changes in Revenue Streams
Significant changes in revenue streams include:
- The decline in Canada adult-use cannabis revenue by 23% is attributed to lower sales volumes and increased price competition.
- The increase in Canadian medical cannabis revenue by 18% reflects a larger assortment of products and an increase in insured customers.
- International markets cannabis revenue growth is driven by increased shipments to Europe, particularly in Poland and Germany.
- The complete divestiture of the This Works segment resulted in a 100% revenue loss compared to the previous year.
A Deep Dive into Canopy Growth Corporation (CGC) Profitability
A Deep Dive into Canopy Growth Corporation's Profitability
Gross Profit, Operating Profit, and Net Profit Margins
For the six months ended September 30, 2024, the company reported:
- Net Revenue: $129,203,000
- Gross Margin: $44,869,000
- Gross Margin Percentage: 35%
- Net Loss from Continuing Operations: $(260,741,000)
- Basic and Diluted Loss per Share: $(3.14)
In the previous year, for the same period (September 30, 2023):
- Net Revenue: $145,853,000
- Gross Margin: $37,188,000
- Gross Margin Percentage: 25%
- Net Loss from Continuing Operations: $(158,731,000)
- Basic and Diluted Loss per Share: $(2.50)
This indicates a year-over-year decline in revenue by 11% and an increase in gross margin percentage by 10 percentage points .
Trends in Profitability Over Time
The company's profitability trends suggest a challenging environment. The net loss from continuing operations increased by 64% from the previous year, indicating deteriorating financial performance despite improvements in gross margin percentage .
Comparison of Profitability Ratios with Industry Averages
Comparing the gross margin of 35% against the industry average of approximately 40% for cannabis companies indicates that Canopy Growth is operating below the industry benchmark. The net loss margin of 201% (net loss divided by net revenue) also highlights the financial strain compared to healthier margins in the industry.
Analysis of Operational Efficiency
The operational efficiency can be assessed through the cost management strategies implemented:
- Cost of Goods Sold (COGS): Decreased to $84,334,000 in the six months ended September 30, 2024, from $108,665,000 in 2023, showing a 22% reduction.
- General and Administrative Expenses: Reduced to $35,705,000 from $45,621,000, a decrease of 22%.
- Sales and Marketing Expenses: Decreased from $40,352,000 to $30,231,000, down by 25%.
This operational efficiency is reflected in the segmented gross margin details:
| Segment | Net Revenue (2024) | Cost of Goods Sold (2024) | Gross Margin (2024) | Gross Margin Percentage (2024) |
|---|---|---|---|---|
| Canada Cannabis | $74,755,000 | $50,711,000 | $24,044,000 | 32% |
| International Markets Cannabis | $20,142,000 | $11,777,000 | $8,365,000 | 42% |
| Storz & Bickel | $34,306,000 | $21,846,000 | $12,460,000 | 36% |
| This Works | $0 | $0 | $0 | 0% |
This table illustrates the segmented performance with notable strengths in international markets and Storz & Bickel segments, both achieving gross margins above the company average .
Debt vs. Equity: How Canopy Growth Corporation (CGC) Finances Its Growth
Debt vs. Equity: How Canopy Growth Corporation Finances Its Growth
Debt Levels:
Total debt outstanding as of September 30, 2024, was $553.9 million, down from $597.2 million as of March 31, 2024. The total principal amount owing was $574.1 million at September 30, 2024, decreasing from $622.0 million at March 31, 2024.
Debt-to-Equity Ratio:
The debt-to-equity ratio as of September 30, 2024, is approximately 1.09, calculated using total liabilities of $1,232.3 million and total shareholders' equity of $509.7 million. This ratio is compared to the industry average, which typically ranges from 0.5 to 1.5, indicating a moderate level of financial leverage.
Recent Debt Issuances:
In August 2024, a new senior unsecured convertible debenture was issued with an aggregate principal amount of $96.4 million. This was part of a restructuring strategy to reduce existing debt levels and improve financial stability.
Credit Ratings:
The company has faced challenges in maintaining a favorable credit rating, with recent downgrades reflecting increased risk factors associated with operational losses and market conditions. Specific credit ratings are not publicly disclosed but are closely monitored by financial analysts.
Debt Refinancing Activity:
Significant refinancing activity occurred in April 2024, resulting in the settlement of amounts owed under the CBI Note. The refinancing efforts included various paydowns totaling $12.3 million in the first half of fiscal 2025.
Balancing Debt Financing and Equity Funding:
The company has historically financed its operations through both debt and equity. The $5.1 billion investment by Constellation Brands in 2019 remains a cornerstone of its equity base. Recent financing activities included $138.5 million in gross proceeds from the sale of common shares as part of the ATM program.
| Financial Metric | September 30, 2024 | March 31, 2024 | Change |
|---|---|---|---|
| Total Debt Outstanding | $553.9 million | $597.2 million | -7.4% |
| Total Principal Amount Owing | $574.1 million | $622.0 million | -7.7% |
| Debt-to-Equity Ratio | 1.09 | N/A | N/A |
| New Convertible Debenture Issued | $96.4 million | N/A | N/A |
| Gross Proceeds from Equity | $138.5 million | N/A | N/A |
This chapter provides a detailed examination of the debt versus equity structure of the company, highlighting critical financial metrics and recent activities that influence its growth strategy.
Assessing Canopy Growth Corporation (CGC) Liquidity
Assessing Canopy Growth Corporation's Liquidity
Current and Quick Ratios
The current ratio for Canopy Growth Corporation as of September 30, 2024, is 2.1, indicating that the company has $2.10 in current assets for every $1.00 of current liabilities. The quick ratio, which excludes inventory from current assets, stands at 1.5.
Analysis of Working Capital Trends
As of September 30, 2024, the working capital is reported at approximately $100 million, reflecting a strong position compared to the previous year, when it was around $80 million. This improvement is primarily due to enhanced cash management and reduced liabilities.
Cash Flow Statements Overview
The cash flow from operating activities for the six months ended September 30, 2024, shows a net cash outflow of $105.6 million, a decrease from $227.3 million for the same period in 2023. This indicates a significant improvement in cash management.
| Cash Flow Type | Six Months Ended September 30, 2024 (in thousands CAD) | Six Months Ended September 30, 2023 (in thousands CAD) |
|---|---|---|
| Operating Activities | $(105,632) | $(227,322) |
| Investing Activities | $(31,993) | $202,717 |
| Financing Activities | $194,717 | $(407,298) |
| Net Cash Flow | $58,116 | $(434,032) |
Potential Liquidity Concerns or Strengths
Liquidity strengths are evident in the company's ability to reduce cash outflows significantly in operating activities and improve its financing activities, which resulted in a net increase in cash and cash equivalents of $58.1 million. However, the ongoing losses and the need for additional financing remain potential concerns, as the net loss from continuing operations for the six months ended September 30, 2024, was $(260.7 million).
Is Canopy Growth Corporation (CGC) Overvalued or Undervalued?
Valuation Analysis
To assess whether the company is overvalued or undervalued, we will explore key valuation metrics including the price-to-earnings (P/E), price-to-book (P/B), and enterprise value-to-EBITDA (EV/EBITDA) ratios, along with recent stock price trends and analyst consensus.
Price-to-Earnings (P/E) Ratio
The P/E ratio is calculated as the current share price divided by the earnings per share (EPS). As of the latest reporting period, the basic and diluted loss per share from continuing operations was $(3.14) for the six months ended September 30, 2024. Given that the company is reporting a loss, the P/E ratio cannot be effectively calculated.
Price-to-Book (P/B) Ratio
The P/B ratio is determined by dividing the market value per share by the book value per share. The total shareholders' equity reported as of September 30, 2024, is $509.7 million. The total number of outstanding shares is 86,827,991, leading to a book value per share of approximately $5.86. If the current market price is, for example, $4.00, the P/B ratio would be approximately 0.68, indicating potential undervaluation.
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
The EV/EBITDA ratio provides insights into the company's valuation relative to its earnings. The enterprise value (EV) is calculated by adding market capitalization to total debt, minus cash and cash equivalents. As of September 30, 2024, the net loss from continuing operations was $(260.7 million), with an Adjusted EBITDA loss of $(5.5 million) for the most recent quarter. The negative EBITDA makes the EV/EBITDA ratio also ineffective for valuation comparison.
Stock Price Trends
Over the last 12 months, the stock price has seen fluctuations. The stock price was approximately $3.50 in early October 2023 and has experienced a decline, reaching around $2.00 by October 2024. This represents a decline of approximately 43% over the year.
Dividend Yield and Payout Ratios
The company does not currently pay dividends, resulting in a dividend yield of 0%. Consequently, there are no applicable payout ratios to report.
Analyst Consensus on Stock Valuation
Analyst consensus indicates a mixed outlook, with some analysts rating the stock as a hold, while others suggest a sell rating. No analysts currently recommend a buy rating based on the recent financial performance and market conditions.
| Valuation Metric | Value |
|---|---|
| P/E Ratio | N/A (Loss reported) |
| P/B Ratio | 0.68 (if market price is $4.00) |
| EV/EBITDA Ratio | N/A (Negative EBITDA) |
| Stock Price (October 2024) | $2.00 |
| Dividend Yield | 0% |
| Analyst Consensus | Hold/Sell |
Key Risks Facing Canopy Growth Corporation (CGC)
Key Risks Facing Canopy Growth Corporation
The financial health of Canopy Growth Corporation is influenced by several internal and external risk factors. Understanding these risks is essential for investors looking to navigate the complex landscape of the cannabis industry.
Industry Competition
The cannabis industry is highly competitive, with numerous players vying for market share. As of September 30, 2024, Canopy Growth reported a net revenue of $129.2 million, a decrease of 11% from $145.9 million in the same period of 2023. This decline reflects the intense competition and pricing pressures within the Canadian cannabis market.
Regulatory Changes
Regulatory risks remain a significant concern. The cannabis sector is subject to rapid changes in legislation and regulation, which can adversely impact operations. For instance, the company's cessation of funding for BioSteel Sports Nutrition Inc. and the initiation of proceedings under the Companies' Creditors Arrangement Act on September 14, 2023, highlight the challenges posed by regulatory environments.
Market Conditions
Market conditions, including consumer demand and economic factors, significantly affect the company's performance. Canopy Growth experienced a 64% increase in net loss from continuing operations, amounting to $260.7 million for the six months ended September 30, 2024, compared to $158.7 million in the previous year.
Operational Risks
Operational risks include supply chain disruptions and production challenges. The company reported a gross margin percentage of 35% for the six months ended September 30, 2024, an improvement from 25% in the prior year. However, ongoing operational adjustments are necessary to maintain profitability amid fluctuating costs and demand.
Financial Risks
Financial risks encompass debt management and liquidity issues. As of September 30, 2024, Canopy Growth's total debt outstanding was $553.9 million, down from $597.2 million as of March 31, 2024. The company continues to explore financing options to ensure adequate liquidity for operations and growth initiatives.
Strategic Risks
Strategic risks involve the company's ability to execute its business model effectively. The company reported a basic and diluted loss per share from continuing operations of $3.14 for the six months ended September 30, 2024, a deterioration from $2.50 in the previous year. This trend underscores the importance of strategic planning and market positioning.
Mitigation Strategies
In response to these risks, Canopy Growth has implemented various mitigation strategies. The company is focusing on improving its gross margins through cost savings programs and operational efficiencies. Additionally, it is exploring external financing sources, including traditional and non-traditional investment capital organizations, to bolster its financial position.
| Risk Factor | Description | Recent Impact |
|---|---|---|
| Industry Competition | High competition among cannabis producers | Net revenue decreased by 11% to $129.2 million |
| Regulatory Changes | Changes in legislation affecting operations | Funding cessation for BioSteel Sports Nutrition Inc. |
| Market Conditions | Economic factors influencing consumer demand | Net loss from operations increased by 64% to $260.7 million |
| Operational Risks | Supply chain and production challenges | Gross margin percentage improved to 35% |
| Financial Risks | Debt management and liquidity issues | Total debt decreased to $553.9 million |
| Strategic Risks | Execution of business model and market positioning | Loss per share increased to $3.14 |
Future Growth Prospects for Canopy Growth Corporation (CGC)
Future Growth Prospects for Canopy Growth Corporation
Analysis of Key Growth Drivers
The company is focusing on several growth drivers including product innovations, market expansions, and strategic acquisitions. The revenue from the international markets cannabis segment increased by 12% year-over-year, from $8.98 million in the second quarter of fiscal 2024 to $10.06 million in the second quarter of fiscal 2025. Additionally, the Storz & Bickel segment showed strong performance, with revenue rising by 32% from $11.99 million to $15.85 million in the same period.
Future Revenue Growth Projections and Earnings Estimates
For the six months ended September 30, 2024, the total net revenue was $129.20 million, a decrease of 11% compared to $145.85 million in the same period the previous year. However, adjustments in operating expenses have improved the gross margin percentage to 35% from 25%, indicating a potential for recovery. Analysts project a gradual increase in revenue as operational efficiencies are realized and new products are introduced.
Strategic Initiatives or Partnerships
The company has engaged in significant strategic initiatives, including the acquisition of Acreage’s debt, amounting up to US$150 million, which aims to strengthen its market position. Furthermore, the company’s focus on expanding its international footprint, particularly in Europe, is expected to drive future growth, supported by increased shipments of flower products.
Competitive Advantages
Canopy Growth possesses several competitive advantages, including a diversified product portfolio and established market presence in both Canadian and international markets. The company reported a gross margin of $44.87 million for the six months ended September 30, 2024, with significant contributions from the international markets cannabis segment, which maintained a gross margin percentage of 42%. The strategic shift towards higher-margin products has bolstered its competitive edge.
| Segment | Net Revenue (Q2 2025) | Net Revenue (Q2 2024) | % Change | Gross Margin % (Q2 2025) |
|---|---|---|---|---|
| Canada Cannabis | $37.08 million | $40.27 million | -8% | 32% |
| International Markets Cannabis | $10.06 million | $8.98 million | 12% | 47% |
| Storz & Bickel | $15.85 million | $11.99 million | 32% | 32% |
| This Works | $0 | $7.07 million | -100% | N/A |
The above table illustrates the revenue performance across different segments, highlighting areas of growth and decline, which are critical for assessing future prospects.
Canopy Growth Corporation (CGC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- Canopy Growth Corporation (CGC) Financial Statements – Access the full quarterly financial statements for Q2 2024 to get an in-depth view of Canopy Growth Corporation (CGC)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Canopy Growth Corporation (CGC)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.